Mastoid obliteration by BMP-2/collagen composites: An experimental study using tissue engineering

Kazunori Nishizaki, Hidetsugu Tsujigiwa, Yasushi Takeda, Tadashi Yoshino, Manabu Maeta, Kunihiro Fukushima, Hitoshi Nagatsuka, Noriyuki Nagai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: Several materials have been used in the application of mastoid cavity obliteration during surgery for cholesteatoma; however, nothing has won universal acceptance. Through the advancement of tissue engineering, bone morphogenetic protein-2 (BMP-2)/collagen composites have been elucidated as inducers of heterogenic bone formation. This study was performed to investigate whether these composites are potentially obliteration materials for use in the mastoid cavity by using an animal experimental study. Materials and Methods: The composites were implanted in the rat mastoid to investigate whether new bone would be tissue engineered in the mastoid and, if so, whether the newly formed bone was stable. The composites were examined histologically over a 24-week period. Results: The composites implanted in the rat mastoid were able to tissue engineer new bone, and the newly formed bone was stable as assessed histologically, with almost normal bone structure, that was not resorbed during the 24-week period. Adverse immunological reactions were not found during our observation. Conclusions: Bone that was tissue engineered by the BMP-2/collagen composites was stable as assessed by histological examination and persisted in the rat mastoid. The present study shows that the composites have the potential to become real materials for use in mastoid obliteration.

Original languageEnglish
Pages (from-to)14-18
Number of pages5
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2003

Fingerprint

Bone Morphogenetic Protein 2
Mastoid
Tissue Engineering
Collagen
Bone and Bones
Cholesteatoma
Osteogenesis
Observation

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Mastoid obliteration by BMP-2/collagen composites : An experimental study using tissue engineering. / Nishizaki, Kazunori; Tsujigiwa, Hidetsugu; Takeda, Yasushi; Yoshino, Tadashi; Maeta, Manabu; Fukushima, Kunihiro; Nagatsuka, Hitoshi; Nagai, Noriyuki.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 24, No. 1, 01.2003, p. 14-18.

Research output: Contribution to journalArticle

@article{a0e23856176f4327b547f3603e9ec0c6,
title = "Mastoid obliteration by BMP-2/collagen composites: An experimental study using tissue engineering",
abstract = "Purpose: Several materials have been used in the application of mastoid cavity obliteration during surgery for cholesteatoma; however, nothing has won universal acceptance. Through the advancement of tissue engineering, bone morphogenetic protein-2 (BMP-2)/collagen composites have been elucidated as inducers of heterogenic bone formation. This study was performed to investigate whether these composites are potentially obliteration materials for use in the mastoid cavity by using an animal experimental study. Materials and Methods: The composites were implanted in the rat mastoid to investigate whether new bone would be tissue engineered in the mastoid and, if so, whether the newly formed bone was stable. The composites were examined histologically over a 24-week period. Results: The composites implanted in the rat mastoid were able to tissue engineer new bone, and the newly formed bone was stable as assessed histologically, with almost normal bone structure, that was not resorbed during the 24-week period. Adverse immunological reactions were not found during our observation. Conclusions: Bone that was tissue engineered by the BMP-2/collagen composites was stable as assessed by histological examination and persisted in the rat mastoid. The present study shows that the composites have the potential to become real materials for use in mastoid obliteration.",
author = "Kazunori Nishizaki and Hidetsugu Tsujigiwa and Yasushi Takeda and Tadashi Yoshino and Manabu Maeta and Kunihiro Fukushima and Hitoshi Nagatsuka and Noriyuki Nagai",
year = "2003",
month = "1",
doi = "10.1053/ajot.2003.13",
language = "English",
volume = "24",
pages = "14--18",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Mastoid obliteration by BMP-2/collagen composites

T2 - An experimental study using tissue engineering

AU - Nishizaki, Kazunori

AU - Tsujigiwa, Hidetsugu

AU - Takeda, Yasushi

AU - Yoshino, Tadashi

AU - Maeta, Manabu

AU - Fukushima, Kunihiro

AU - Nagatsuka, Hitoshi

AU - Nagai, Noriyuki

PY - 2003/1

Y1 - 2003/1

N2 - Purpose: Several materials have been used in the application of mastoid cavity obliteration during surgery for cholesteatoma; however, nothing has won universal acceptance. Through the advancement of tissue engineering, bone morphogenetic protein-2 (BMP-2)/collagen composites have been elucidated as inducers of heterogenic bone formation. This study was performed to investigate whether these composites are potentially obliteration materials for use in the mastoid cavity by using an animal experimental study. Materials and Methods: The composites were implanted in the rat mastoid to investigate whether new bone would be tissue engineered in the mastoid and, if so, whether the newly formed bone was stable. The composites were examined histologically over a 24-week period. Results: The composites implanted in the rat mastoid were able to tissue engineer new bone, and the newly formed bone was stable as assessed histologically, with almost normal bone structure, that was not resorbed during the 24-week period. Adverse immunological reactions were not found during our observation. Conclusions: Bone that was tissue engineered by the BMP-2/collagen composites was stable as assessed by histological examination and persisted in the rat mastoid. The present study shows that the composites have the potential to become real materials for use in mastoid obliteration.

AB - Purpose: Several materials have been used in the application of mastoid cavity obliteration during surgery for cholesteatoma; however, nothing has won universal acceptance. Through the advancement of tissue engineering, bone morphogenetic protein-2 (BMP-2)/collagen composites have been elucidated as inducers of heterogenic bone formation. This study was performed to investigate whether these composites are potentially obliteration materials for use in the mastoid cavity by using an animal experimental study. Materials and Methods: The composites were implanted in the rat mastoid to investigate whether new bone would be tissue engineered in the mastoid and, if so, whether the newly formed bone was stable. The composites were examined histologically over a 24-week period. Results: The composites implanted in the rat mastoid were able to tissue engineer new bone, and the newly formed bone was stable as assessed histologically, with almost normal bone structure, that was not resorbed during the 24-week period. Adverse immunological reactions were not found during our observation. Conclusions: Bone that was tissue engineered by the BMP-2/collagen composites was stable as assessed by histological examination and persisted in the rat mastoid. The present study shows that the composites have the potential to become real materials for use in mastoid obliteration.

UR - http://www.scopus.com/inward/record.url?scp=12244279935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244279935&partnerID=8YFLogxK

U2 - 10.1053/ajot.2003.13

DO - 10.1053/ajot.2003.13

M3 - Article

C2 - 12579477

AN - SCOPUS:12244279935

VL - 24

SP - 14

EP - 18

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 1

ER -